Position in MRK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,260,302
+$373,824 QoQ
Shares Held
25,372
+5.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#1,289
of 3,769 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McAdam, LLC holds $23,291,732 across 9 Drug Manufacturers - General names. MRK ranks #4 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,221 | $5,643,467 | |
| 2 | LLY |
ELI LILLY & Co
|
4,144 | $4,970,438 | |
| 3 | ABBV |
AbbVie Inc.
|
17,535 | $4,412,507 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
25,372 | $3,260,302 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
25,513 | $3,223,312 | |
| 6 | PFE |
Pfizer Inc
|
27,456 | $661,140 | |
| 7 | AMGN |
Amgen Inc
|
1,375 | $497,915 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,403 | $368,940 |
All Filings in MRK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,260,302 | 25,372 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,886,478 | 23,996 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,159,408 | 20,515 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,714,186 | 20,424 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,595,311 | 20,153 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,667,381 | 18,576 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $1,856,694 | 18,664 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,038,515 | 17,951 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,071,545 | 16,733 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,131,652 | 16,155 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,760,454 | 16,148 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,583,473 | 15,381 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,686,540 | 14,616 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,005,279 | 9,449 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $334 | 4,352 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $656,837 | 7,627 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $441,992 | 4,848 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $350,681 | 4,274 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $333,537 | 4,352 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $311,481 | 4,147 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $340,477 | 4,378 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $247,844 | 3,215 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $233,620 | 2,856 | Shares | Sole | 2021-01-12 | |
| No filing history on record for this holder in this stock. | ||||||